Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
How does huperzine A from club moss work in the brain?
Huperzine A, the primary active compound in Club Moss (Huperzia serrata), functions as a potent and selective acetylcholinesterase inhibitor. By blocking the enzyme that breaks down acetylcholine, it increases available acetylcholine levels in the brain, supporting memory and cognitive function. This mechanism is similar to prescription Alzheimer's medications like donepezil. Research evidence is rated Level C, meaning controlled trials exist but quality is limited. This cholinergic mechanism explains both its traditional Chinese medicine use for memory enhancement and modern interest in Alzheimer's disease applications.
Can I take club moss or huperzine A with Alzheimer's medications?
Club moss and huperzine A should NOT be combined with prescription Alzheimer's medications such as donepezil (Aricept), rivastigmine (Exelon), or galantamine. Since both huperzine A and these drugs are acetylcholinesterase inhibitors, combining them can cause excessive acetylcholine levels, leading to serious side effects including severe nausea, vomiting, muscle weakness, dangerously slow heart rate, and seizures. Always consult a healthcare provider before using club moss alongside any cognitive or neurological medications to avoid harmful interactions.
What is the recommended dosage of huperzine A from club moss?
The typical adult dosage of huperzine A extracted from Club Moss is 50-200 micrograms (mcg) daily, often divided into one or two doses. Standardized extracts are preferred to ensure consistent potency. Due to huperzine A's long half-life of approximately 10-14 hours, some practitioners recommend cycling use with periodic breaks. Evidence for optimal dosing remains limited (Level C). Always start with the lowest effective dose and consult a qualified healthcare practitioner, as individual needs vary based on health status and concurrent medications.
Is club moss (Huperzia serrata) safe during pregnancy and breastfeeding?
Club moss is considered unsafe during pregnancy and breastfeeding. Huperzine A crosses the blood-brain barrier and may affect fetal and infant neurological development. Its acetylcholinesterase-inhibiting properties could cause unpredictable effects on developing nervous systems. Women who are pregnant, planning to become pregnant, or breastfeeding should avoid club moss and huperzine A supplements entirely. Consult a qualified healthcare provider for safe alternatives to support cognitive health during pregnancy and lactation.
What are the side effects of taking club moss supplements?
Common side effects of club moss and huperzine A include nausea, diarrhea, and insomnia, particularly at higher doses. More serious adverse effects can include slow heart rate (bradycardia) and increased seizure risk, especially in individuals with seizure disorders. These effects result from elevated acetylcholine levels affecting both the central nervous system and peripheral body functions. Club moss is contraindicated for individuals with heart rhythm disorders, seizure history, or those taking anticholinesterase medications. Discontinue use if adverse effects occur and seek medical attention.
Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Huperzia serrata is a traditional Chinese medicinal herb containing the alkaloid Huperzine A, which is used for the treatment of Alzheimer's disease and other cognitive impairments [PMID:31778363, PMID:14725492, PMID:28807163].
Contexte
Huperzia serrata, also known as Qian Ceng Ta, is a member of the Lycopodiaceae family [PMID:38697240, PMID:19938535]. It is an endangered species due to overexploitation [PMID:31346505, PMID:34072855].
Usages traditionnels
Traditionally used in Chinese medicine for treating rheumatic numbness, arthritic pain, dysmenorrhea, contusions, strains, swellings, schizophrenia, myasthenia gravis, and organophosphate poisoning [PMID:38697240, PMID:17644292, PMID:19938535].
Composés actifs
The plant contains lycopodium alkaloids, most notably Huperzine A [PMID:31351127, PMID:14725492]. Other identified compounds include huperradines A-K, hupertimines A-E, serratane-type triterpenoids, phenolic acids (caffeic acid and ferulic acid), flavonoids, and polysaccharides [PMID:38697240, PMID:35604198, PMID:15248614, PMID:34526893, PMID:39571762].
Mécanisme d'action
Huperzine A acts as a potent, selective, and slow reversible inhibitor of acetylcholinesterase (AChE) [PMID:14725492, PMID:19240260, PMID:18565502]. It may also exert neuroprotective effects by interacting with alpha-7 and alpha-4-beta-2 nicotinic acetylcholine receptors, suppressing NF-kappaB signaling, and reducing pro-inflammatory cytokines like IL-1beta and TNF-alpha [PMID:27086593, PMID:34770940].
Preuves cliniques
Preuve CAlzheimer's Disease
Huperzine A has shown promising effects on cognitive functions, improvement in activities of daily living, and neuropsychiatric symptoms in clinical trials [PMID:28807163, PMID:35384262].
Preuve CVascular Dementia
Huperzine A has been proven to significantly improve learning and memory impairment in patients [PMID:18565502].
Sécurité et effets indésirables
Huperzine A is described as well-tolerated [PMID:18565502], although some chemical drugs for Alzheimer's are noted to have significant adverse reactions [PMID:31778363].
Synthèse des preuves
Evidence is primarily based on reviews and preclinical studies (Level C and D), with mentions of Phase II and III clinical trials for Huperzine A in the treatment of Alzheimer's disease.
Sources PubMed
1.PMID: 31778363 (2019) — The use of Huperzia species for the treatment of Alzheimer's disease. · Journal of basic and clinical physiology and pharmacology
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
— Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease.
· IUBMB life
7.PMID: 21791295 (2011) — Traditional Chinese medicines and Alzheimer's disease. · Taiwanese journal of obstetrics & gynecology
8.PMID: 38697240 (2024) — Lycopodium alkaloids from Huperzia serrata and their cholinesterase inhibitory activities. · Phytochemistry
9.PMID: 31376517 (2019) — Ethnopharmacology of the club moss subfamily Huperzioideae (Lycopodiaceae, Lycopodiophyta): A phylogenetic and chemosystematic perspective. · Journal of ethnopharmacology
10.PMID: 15248614 (2004) — Serratane-type triterpenoids from Huperzia serrata. · Natural product research
12.PMID: 37507844 (2023) — Lycopodium Alkaloids from Huperzia serrata and Their Anti-acetylcholinesterase Activities. · Chemistry & biodiversity
13.PMID: 17644292 (2007) — Huperzine A from Huperzia species--an ethnopharmacolgical review. · Journal of ethnopharmacology
14.PMID: 40689330 (2025) — A perspective on the mechanisms of herbal medicine for cognitive impairment. · Frontiers in neurology
15.PMID: 19240260 (2009) — Role of huperzine a in the treatment of Alzheimer's disease. · The Annals of pharmacotherapy
16.PMID: 27086593 (2016) — Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research. · Expert review of neurotherapeutics
17.PMID: 39571762 (2025) — Pharmacology, phytochemistry, and traditional uses of Huperzia serrata (Thunb. ex Murray) Trev. · Fitoterapia
18.PMID: 34526893 (2021) — Huperzia serrata Extract 'NSP01' With Neuroprotective Effects-Potential Synergies of Huperzine A and Polyphenols. · Frontiers in pharmacology
19.PMID: 34770940 (2021) — Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease. · Molecules (Basel, Switzerland)
20.PMID: 18565502 (2008) — Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia. · Chemico-biological interactions
21.PMID: 31346505 (2019) — Development of polymorphic simple sequence repeat markers in Huperzia serrata (Lycopodiaceae). · Applications in plant sciences
22.PMID: 34072855 (2021) — In Vitro Propagation, Huperzine A Content and Antioxidant Activity of Three Genotypic Huperzia serrata. · Plants (Basel, Switzerland)
23.PMID: 19938535 (2009) — [Research advances of Huperzia serrata (Thunb.) Trev]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica